GSK plc (GLAXF PINK) stock market data APIs
$21.6873
0(0%)
as of November 7, 2025
Try our APIs with
free plan!
GSK plc Financial Data Overview
Price chart is built with
Anychart
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in London, United Kingdom.
Prev. Close
21.6873
Open
21.6873
High
21.7465
Low
21.6873
52 wk Range
14.9969-23.46
Market Cap
91 665 M
P/E Ratio
12.5376
Shares Outstanding
4 019 M
Revenue
32 166 M
EPS
0.6617
Dividends (Yield)
0.0289
Beta
0.231
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GSK plc data using free add-ons & libraries
Get GSK plc Fundamental Data
GSK plc Fundamental data includes:
- Net Revenue: 32 166 M
- EBITDA: 9 519 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-29
- EPS/Forecast: 0.47
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GSK plc News
New
Evaluating GSK's 34% Rise as Pipeline Progress Sparks New Valuation Debate
Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight ...
Lupus Nephritis Drugs Markets: A Global and Regional Analysis 2025-2035 - Unmet Needs in Lupus Nephritis Fuel R&D Investments and Market Growth
Company Logo Recent approvals of Benlysta and Lupkynis highlight a shift towards targeted therapies with improved profiles. Despite challenges like high costs and heterogeneous disease presentation, ...
Premenstrual Syndrome (PMS) Treatment Market: Global Industry Outlook with Company Analysis Report 2025-2033
Company Logo Factors like healthcare access, urbanization, and innovation, particularly in the U.S., France, and China, propel market expansion. Key players such as Pfizer, Bayer, and GlaxoSmithKline...
Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans
Moderna MRNA incurred a loss of 51 cents per share in the third quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of $2.15. In the year-ago period, the company had reported earning...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
